Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

類似資料

• Can a Female Donor for a Male Recipient Decrease Relapse Rate for Patients with AML Treated with Allogeneic Hematopoietic Stem Cell Transplantation?
  著者:: Kongtim, Piyanuch, 等
  出版事項: (2014)
• Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation
  著者:: Bachegowda, Lohith S., 等
  出版事項: (2017)
• Similar Transplant Outcomes for AML/MDS Patients with Haploidentical versus 10/10 HLA Matched Unrelated and Related Donors
  著者:: Di Stasi, Antonio, 等
  出版事項: (2014)
• Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
  著者:: Ciurea, Stefan O., 等
  出版事項: (2017)
• Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant -Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic syndrome
  著者:: Kongtim, Piyanuch, 等
  出版事項: (2018)